Overview
Lisa Maragakis, M.D., M.P.H., FSHEA, FIDSA is a professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Dr. Maragakis is the Senior Director of Infection Prevention, for The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. In these roles, she is responsible for the conceptualization, planning, implementation, and development of the Johns Hopkins Health System's infection control and prevention program. Her research interests are the epidemiology, prevention and control of healthcare-acquired infections and antimicrobial-resistant gram-negative bacilli. Dr. Maragakis serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She also serves as the IDSA Co-Chair for the 2022 Update of the Compendium of Strategies to Prevent Healthcare-Associated Infections, and as Co-Chair of the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC).
Dr. Maragakis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Ebola Virus Disease, Severe Acute Respiratory Syndrome (SARS), and Viral Hemorrhagic Fever.
Dr. Maragakis is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 115 peer reviewed articles. Dr. Maragakis is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine. Dr. Durbin is currently accepting new patients.
Office
Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
The Johns Hopkins Hospital
John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine. Dr. Baddley is currently accepting new patients.
Frequently Asked Questions about Dr. Lisa L. Maragakis
How do I make an appointment with Dr. Lisa L. Maragakis?
You can book an appointment with Dr. Lisa L. Maragakis by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lisa L. Maragakis a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lisa L. Maragakis is classified as an Advanced expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lisa L. Maragakis specialize in?
While Dr. Lisa L. Maragakis is a Infectious Disease, they have specific expertise in Methicillin-Resistant Staphylococcus Aureus (MRSA), Ebola Virus Disease, and Severe Acute Respiratory Syndrome (SARS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Lisa L. Maragakis participate in research or clinical trials?
Yes. Dr. Lisa L. Maragakis has published 115 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Dr. Lisa L. Maragakis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Lisa L. Maragakis accept my insurance?
Dr. Lisa L. Maragakis accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Experienced
- COVID-19Dr. Maragakis isExperienced. Learn about COVID-19.
- Ebola Virus DiseaseDr. Maragakis isExperienced. Learn about Ebola Virus Disease.
- Hospital-Acquired PneumoniaDr. Maragakis isExperienced. Learn about Hospital-Acquired Pneumonia.
- MeaslesDr. Maragakis isExperienced. Learn about Measles.
- PneumoniaDr. Maragakis isExperienced. Learn about Pneumonia.
- SepsisDr. Maragakis isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)Dr. Maragakis isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Viral Hemorrhagic FeverDr. Maragakis isExperienced. Learn about Viral Hemorrhagic Fever.